Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Kidney Disease
Intervention:
Sponsor: University of California, San Francisco
Recruiting - verified February 2010
Condition: Pharmacokinetics
Interventions: Drug: colchicine 0.6 mg; Drug: colchicine 0.6 mg; Drug: colchicine; Drug: colchicine; Drug: colchicine
Sponsor: Mutual Pharmaceutical Company, Inc.
Recruiting - verified March 2010
Condition: Healthy
Interventions: Drug: single dose NJ-39758979/ matching placebo; Drug: multi-dose JNJ-39758979 /matching placebo
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Recruiting - verified March 2010
Condition: Alzheimer Disease
Interventions: Drug: BMS-708163; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified January 2010
Condition: Otitis Media
Intervention: Device: Acclarent Iontophoresis System
Sponsor: Acclarent
Recruiting - verified January 2010
Condition: Healthy
Intervention: Drug: HM10760A or placebo
Sponsor: Hanmi Pharmaceutical Company Limited
Recruiting - verified February 2010
Condition: Hepatic Insufficiency
Intervention: Drug: BMS-650032
Sponsor: Bristol-Myers Squibb
Recruiting - verified December 2009
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365; Drug: Placebo
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Conditions: Haemophilus Influenzae Type B Related Disease; Pneumonia; Meningitis; Cellulitis; Osteomyelitis; Epiglottis
Interventions: Biological: InfanrixTM; Biological: GSK Biologicals' Haemophilus inluenzae type b vaccine (GSK 208108); Biological: ActHIBTM; Biological: PentacelTM; Biological: PediarixTM; Biological: PrevnarTM; Biological: RotarixTM; Biological: EngerixTM-B
Sponsor: GlaxoSmithKline
Not yet recruiting - verified March 2010
Condition: Healthy
Intervention: Drug: ABT-384
Sponsor: Abbott
Recruiting - verified February 2010
Condition: Acute Myocardial Infarction
Intervention:
Sponsor: Scripps Translational Science Institute
Recruiting - verified March 2010
Condition: Asthma
Interventions: Drug: ABT-308; Drug: ABT-308; Drug: Placebo; Drug: Placebo
Sponsor: Abbott
Recruiting - verified January 2010
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Nonmalignant Neoplasm
Interventions: Biological: trivalent influenza vaccine; Other: immunoenzyme technique; Other: laboratory biomarker analysis
Sponsors: Beckman Research Institute; National Cancer Institute (NCI)
Recruiting - verified August 2009
Conditions: Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Nonmalignant Neoplasm; Viral Infection
Interventions: Other: cytology specimen collection procedure; Other: fluorescent antibody technique; Procedure: assessment of therapy complications
Sponsors: Beckman Research Institute; National Cancer Institute (NCI)
Recruiting - verified August 2009
Condition: Hepatitis C Virus
Interventions: Drug: BMS-791325; Drug: BMS-791325; Drug: BMS-791325; Drug: BMS-791325; Drug: BMS-791325; Drug: BMS-791325; Drug: Placebo; Drug: Placebo; Drug: Placebo; Drug: Placebo
Sponsor: Bristol-Myers Squibb
Not yet recruiting - verified November 2009
Condition: Psoriasis
Intervention: Drug: CNTO 1959; Placebo
Sponsor: Centocor, Inc.
Recruiting - verified February 2010
Condition: Healthy
Interventions: Biological: MEDI-559; Other: Placebo; Biological: MEDI-559
Sponsor: MedImmune LLC
Recruiting - verified March 2010
Conditions: Alzheimer Disease; Amyloid Beta-Protein
Intervention: Drug: BAY94-9172 (ZK 6013443)
Sponsor: Bayer
Recruiting - verified February 2010
Condition: Retinoblastoma
Interventions: Genetic: DNA ploidy analysis; Genetic: DNA stability analysis; Genetic: Southern blotting; Genetic: genetic linkage analysis; Genetic: loss of heterozygosity analysis; Genetic: mutation analysis; Genetic: polymorphism analysis; Genetic: reverse transcriptase-polymerase chain reaction; Other: questionnaire administration; Other: study of socioeconomic and demographic variables; Procedure: evaluation of cancer risk factors; Procedure: mutation carrier screening
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010
Condition: Healthy
Interventions: Drug: Pregabalin; Drug: Placebo
Sponsor: Pfizer
Recruiting - verified March 2010
All Categories ... Healthy Participants » ... United States » ... California 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
